Activation of the interferon-inducible (2'-5') oligoadenylate synthetase by the Epstein-Barr virus RNA, EBER-1.

The 2'-5' oligoadenylate synthetases and the protein kinase PKR are both interferon-induced, double-stranded RNA-dependent proteins that play important roles in the antiviral effects of the interferons and in cellular growth control. Both enzymes are activated by natural or synthetic dsRNAs and by single-stranded RNAs that possess extensive secondary structure. This report describes the effects of the small Epstein-Barr virus-encoded RNA EBER-1 on the regulation of 2-5(A) synthetase activity. We demonstrate that EBER-1 RNA binds to and activates the human 40-kDa 2-5(A) synthetase in a dose-dependent manner. The efficiency of EBER-1 as an activator of 2-5(A) synthetase is approximately 25% of that of the synthetic double-stranded RNA poly(I)/poly(C), and poly(I)/poly(C) further stimulates enzyme activity even in the presence of a high concentration of EBER-1. Conversely, EBER-1 neither stimulates nor inhibits 2-5(A) synthetase that has been activated by a high concentration of poly(I)/poly(C). Competitive binding assays suggest that the relative affinity of the enzyme for poly(I)/poly(C) is considerably higher than that for EBER-1. Our data indicate that EBER-1, like VAI RNA of adenovirus, TAR RNA of HIV-1, and Rex-RE RNA of HTLV-1, is able to activate the 2-5(A) synthetases. The significance of why several viruses may activate the 2-5(A) synthetase/RNase L-mediated RNA degradation pathway is discussed.

[1]  C. Bisbal,et al.  RNase L Inhibitor Is Induced during Human Immunodeficiency Virus Type 1 Infection and Down Regulates the 2-5A/RNase L Pathway in Human T Cells , 1999, Journal of Virology.

[2]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[3]  Mark R. Player,et al.  The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation , 1998, Pharmacology & Therapeutics.

[4]  C. Rivas,et al.  Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. , 1998, Virology.

[5]  S. Moestrup,et al.  Activation of 2′-5′ Oligoadenylate Synthetase by Single-stranded and Double-stranded RNA Aptamers* , 1998, The Journal of Biological Chemistry.

[6]  M J Clemens,et al.  The double-stranded RNA-dependent protein kinase PKR: structure and function. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[7]  M. Clemens,et al.  Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome. , 1996, Nucleic acids research.

[8]  M. Mathews,et al.  Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach , 1996, Journal of virology.

[9]  J. Langland,et al.  When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. , 1996, Virology.

[10]  V. M. Pain.  Initiation of protein synthesis in eukaryotic cells. , 1996, European journal of biochemistry.

[11]  Tyson V. Sharp,et al.  Regulation of the interferon-inducible protein kinase PKR and (2'-5')oligo(adenylate) synthetase by a catalytically inactive PKR mutant through competition for double-stranded RNA binding. , 1995, European journal of biochemistry.

[12]  G. Ghadge,et al.  Activation of Interferon-inducible 2′5′ Oligoadenylate Synthetase by Adenoviral VAI RNA (*) , 1995, The Journal of Biological Chemistry.

[13]  E. Mordechai,et al.  Activation of the interferon-inducible enzymes, 2',5'-oligoadenylate synthetase and PKR by human T-cell leukemia virus type I Rex-response element. , 1995, Virology.

[14]  M. Mathews,et al.  Two functionally distinct RNA-binding motifs in the regulatory domain of the protein kinase DAI , 1995, Molecular and cellular biology.

[15]  B. Williams,et al.  HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. , 1994, Virology.

[16]  J. Steitz,et al.  The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M J Clemens,et al.  Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. , 1993, Nucleic acids research.

[18]  R. Silverman,et al.  A dominant negative mutant of 2‐5A‐dependent RNase suppresses antiproliferative and antiviral effects of interferon. , 1993, The EMBO journal.

[19]  Robert H. Silverman,et al.  Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action , 1993, Cell.

[20]  M. Mathews,et al.  Tat-responsive region RNA of human immunodeficiency virus type 1 stimulates protein synthesis in vivo and in vitro: relationship between structure and function. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Mathews,et al.  Interactions between double-stranded RNA regulators and the protein kinase DAI , 1992, Molecular and cellular biology.

[22]  Ganes C. Sen,et al.  Identification of the double-stranded RNA-binding domain of the human interferon-inducible protein kinase. , 1992, The Journal of biological chemistry.

[23]  P. Lengyel,et al.  The interferon system. A bird's eye view of its biochemistry. , 1992, The Journal of biological chemistry.

[24]  M. Mathews,et al.  Adenovirus virus-associated RNA and translation control , 1991, Journal of virology.

[25]  R. Kumar,et al.  Cloning, sequencing, and expression of two murine 2'-5'-oligoadenylate synthetases. Structure-function relationships. , 1991, The Journal of biological chemistry.

[26]  W. Greene,et al.  The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Katze,et al.  The integrity of the stem structure of human immunodeficiency virus type 1 Tat-responsive sequence of RNA is required for interaction with the interferon-induced 68,000-Mr protein kinase , 1991, Journal of virology.

[28]  K. Hilse,et al.  Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. , 1991, Nucleic Acids Research.

[29]  P. Krieg,et al.  Improved synthesis of full-length RNA probe at reduced incubation temperatures. , 1990, Nucleic acids research.

[30]  M. Clemens,et al.  Translational control by the Epstein-Barr virus small RNA EBER-1. Reversal of the double-stranded RNA-induced inhibition of protein synthesis in reticulocyte lysates. , 1990, European journal of biochemistry.

[31]  E. Coccia,et al.  A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. , 1990, Virology.

[32]  M. Mathews,et al.  Removal of double-stranded contaminants from RNA transcripts: synthesis of adenovirus VA RNAI from a T7 vector. , 1990, Nucleic acids research.

[33]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[34]  T. Okamoto,et al.  Binding of Tat protein to TAR region of human immunodeficiency virus type 1 blocks TAR-mediated activation of (2'-5')oligoadenylate synthetase. , 1990, AIDS research and human retroviruses.

[35]  A. Hovanessian.  The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. , 1989, Journal of interferon research.

[36]  B. Williams,et al.  Constitutive expression of a 2',5'-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. , 1989, Journal of interferon research.

[37]  J. Karn,et al.  Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Y. Kuchino,et al.  Modulation of nuclear matrix-associated 2',5'-oligoadenylate metabolism and ribonuclease L activity in H9 cells by human immunodeficiency virus. , 1989, The Journal of biological chemistry.

[39]  C. Bisbal,et al.  Characterization of two murine (2'-5')(A)n-dependent endonucleases of different molecular mass. , 1989, European journal of biochemistry.

[40]  R. Silverman,et al.  Purification and analysis of murine 2-5A-dependent RNase. , 1988, The Journal of biological chemistry.

[41]  J. Steitz,et al.  Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells , 1988, Journal of virology.

[42]  M. Vigneron,et al.  Constitutive expression of (2′–5′) oligo A synthetase confers resistance to picornavirus infection , 1987, Nature.

[43]  M. Yoshida,et al.  Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Hovanessian,et al.  Four different forms of interferon-induced 2',5'-oligo(A) synthetase identified by immunoblotting in human cells. , 1987, The Journal of biological chemistry.

[45]  M. Katze,et al.  Adenovirus VAI RNA complexes with the 68 000 Mr protein kinase to regulate its autophosphorylation and activity. , 1987, The EMBO journal.

[46]  D. Capon,et al.  Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein , 1987, Cell.

[47]  M. Seiki,et al.  The second pX product p27 x‐III of HTLV‐1 is required for gag gene expression , 1986, FEBS letters.

[48]  R. Bhat,et al.  Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus , 1985, Journal of virology.

[49]  L. Lasky,et al.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus , 1985, Nature.

[50]  I. Kerr,et al.  Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase. , 1984, European journal of biochemistry.

[51]  I. Kerr,et al.  Virus-mediated inhibition of the ppp(A2'p)nA system and its prevention by interferon. , 1982, Biochemical and biophysical research communications.

[52]  J. Steitz,et al.  Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Lengyel,et al.  Synthesis of (2'-5')(A)n from ATP. Characteristics of the reaction catalyzed by (2'-5')(A)n synthetase purified from mouse Ehrlich ascites tumor cells treated with interferon. , 1980, The Journal of biological chemistry.

[54]  L. A. Ball,et al.  INDUCTION, PURIFICATION, AND PROPERTIES OF 2′5′ OLIGOADENYLATE SYNTHETASE , 1980, Annals of the New York Academy of Sciences.

[55]  L. A. Ball,et al.  Induction of 2'5'-oligoadenylate synthetase activity and a new protein by chick interferon. , 1979, Virology.

[56]  B. Williams,et al.  Inhibition of cell-free protein synthesis by pppA2′ p5′ A2′ p5′ A: a novel oligonucleotide synthesized by interferon-treated L cell extracts , 1978, Cell.

[57]  Tyson V. Sharp,et al.  Regulation of the interferon-inducible eIF-2α protein kinase by small RNAs , 1994 .

[58]  D. O'reilly,et al.  Baculovirus expression vectors: a laboratory manual. , 1992 .

[59]  J. Hershey,et al.  Translational control in mammalian cells. , 1991, Annual review of biochemistry.

[60]  W. Müller,et al.  Alteration of nuclear (2'-5')oligoriboadenylate synthetase and nuclease activities preceding replication of human immunodeficiency virus in H9 cells. , 1988, Biological chemistry Hoppe-Seyler.

[61]  K C Zoon,et al.  Interferons and their actions. , 1987, Annual review of biochemistry.

[62]  T. Nilsen,et al.  Molecular mechanisms of action of interferon. , 1981, Texas reports on biology and medicine.

[63]  I. Kerr,et al.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.